Cerium oxide nanoparticles inhibit the migration and proliferation of gastric cancer by increasing DHX15 expression

International Journal of Nanomedicine

Volumn 11, Issue , 2016, Pages 3023-3034

  Xiao, Yu Feng ^a   Li, Jian Mei ^a   Wang, Su Min ^a   Yong, Xin ^a   Tang, Bo ^a   Jie, Meng Meng ^a   Dong, Hui ^a   Yang, Xiao Chao ^a   Yang, Shi Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cerium oxide nanoparticles; DHX15; Gastric cancer; P38

Indexed keywords

CERIUM OXIDE NANOPARTICLE; DEAH BOX HELICASE 15; RNA HELICASE; UNCLASSIFIED DRUG; CERIC OXIDE; CERIUM; DHX15 PROTEIN, HUMAN; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STOMACH CANCER; ANIMAL; CELL MOTION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CERIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE, NUDE; NANOPARTICLES; NEOPLASM METASTASIS; RNA HELICASES; STOMACH NEOPLASMS;

EID: 85006789637     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S103648     Document Type: Article

References (33)

1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.
2. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-E386.
3. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977-1010.
4. Bleeker EA, de Jong WH, Geertsma RE, et al. Considerations on the EU definition of a nanomaterial: science to support policy making. Regul Toxicol Pharmacol. 2013;65(1):119-125.
5. Wang J, Gu H. Novel metal nanomaterials and their catalytic applications. Molecules. 2015;20(9):17070-17092.
6. Goris B, Bals S, Van den Broek W, et al. Atomic-scale determination of surface facets in gold nanorods. Nat Mater. 2012;11(11):930-935.
7. Baumann J, Sakka Y, Bertrand C, Koser J, Filser J. Adaptation of the Daphnia sp. acute toxicity test: miniaturization and prolongation for the testing of nanomaterials. Environ Sci Pollut Res Int. 2014; 21(3):2201-2213.
8. Veiseh O, Tang BC, Whitehead KA, Anderson DG, Langer R. Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov. 2015;14(1):45-57.
9. Mao HY, Laurent S, Chen W, et al. Graphene: promises, facts, opportunities, and challenges in nanomedicine. Chem Rev. 2013;113(5): 3407-3424.
10. Thakor AS, Gambhir SS. Nanooncology: the future of cancer diagnosis and therapy. CA Cancer J Clin. 2013;63(6):395-418.
11. 4 nanoroses with five unique functions for cancer cell targeting, imaging and therapy. Adv Funct Mater. 2014;24(12):1772-1780.
12. Liu Y, Bai J, Jia X, Jiang X, Guo Z. Fabrication of multifunctional SiO2@GN-serum composites for chemo-photothermal synergistic therapy. ACS Appl Mater Interfaces 2015;7(1):112-121.
13. Wang Y, Chen J, Irudayaraj J. Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2+ breast cancer. ACS Nano. 2011;5(12):9718-9725.
14. Babu KS, Anandkumar M, Tsai TY, Kao TH, Stephen Inbaraj B, Chen BH. Cytotoxicity and antibacterial activity of gold-supported cerium oxide nanoparticles. Int J Nanomedicine. 2014;9:5515-5531.
15. Lin W, Huang YW, Zhou XD, Ma Y. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol. 2006;25(6):451-457.
16. Pesic M, Podolski-Renic A, Stojkovic S, et al. Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity. Chem Biol Interact. 2015;232:85-93.
17. Yang ZY, Luo SL, Li H, et al. Alendronate as a robust anchor for ceria nanoparticle surface coating: facile binding and improved biological properties. RSC Adv. 2014;4(104):59965-59969.
18. Hussain S, Al-Nsour F, Rice AB, et al. Cerium dioxide nanoparticles induce apoptosis and autophagy in human peripheral blood monocytes. ACS Nano. 2012;6(7):5820-5829.
19. Mosallanejad K, Sekine Y, Ishikura-Kinoshita S, et al. The DEAH-box RNA helicase DHX15 activates NF-kappaB and MAPK signaling downstream of MAVS during antiviral responses. Sci Signal. 2014; 7(323):ra40.
20. Asati A, Santra S, Kaittanis C, Perez JM. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano. 2010;4(9):5321-5331.
21. Alili L, Sack M, von Montfort C, et al. Downregulation of tumor growth and invasion by redox-active nanoparticles. Antioxid Redox Signal. 2013;19(8):765-778.
22. Wason MS, Colon J, Das S, et al. Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production. Nanomedicine. 2013;9(4):558-569.
23. Colon J, Hsieh N, Ferguson A, et al. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine. 2010;6(5):698-705.
24. Pagliari F, Mandoli C, Forte G, et al. Cerium oxide nanoparticles protect cardiac progenitor cells from oxidative stress. ACS Nano. 2012; 6(5):3767-3775.
25. Rubio L, Annangi B, Vila L, Hernandez A, Marcos R. Antioxidant and anti-genotoxic properties of cerium oxide nanoparticles in a pulmonary-like cell system. Arch Toxicol. 2016;90(2):269-278.
26. Wang P, Zhu S, Yang L, et al. Nlrp6 regulates intestinal antiviral innate immunity. Science. 2015;350(6262):826-830.
27. Niu Z, Jin W, Zhang L, Li X. Tumor suppressor RBM5 directly interacts with the DExD/H-box protein DHX15 and stimulates its helicase activity. FEBS Lett. 2012;586(7):977-983.
28. Grossi V, Peserico A, Tezil T, Simone C. p38alpha MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol. 2014;20(29):9744-9758.
29. Gupta J, del Barco Barrantes I, Igea A, et al. Dual function of p38al-pha MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival. Cancer Cell. 2014; 25(4):484-500.
30. Zhong W, Zhu H, Sheng F, et al. Activation of the MAPK11/12/13/14 (p38 MAPK) pathway regulates the transcription of autophagy genes in response to oxidative stress induced by a novel copper complex in HeLa cells. Autophagy. 2014;10(7):1285-1300.
31. Hao W, Yuan X, Yu L, et al. Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways. Sci Rep. 2015;5:10336.
32. Wang N, Feng YX, Zeng LL, Zhao ZN, Chen TF. Functionalized multiwalled carbon nanotubes as carriers of ruthenium complexes to antagonize cancer multidrug resistance and radioresistance. ACS Appl Mater Interfaces. 2015;7(27):14933-14945.
33. Kumar A, Huo S, Zhang X, et al. Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment. ACS Nano. 2014;8(5):4205-4220.